INOVIO 将于 11 月 10 日发布 2026 年第三季度财务业绩
INOVIO to Report Third Quarter 2026 Financial Results on November 10, 2026
INOVIO 宣布其 2026 年第三季度财务业绩将于 11 月 10 日美股收盘后发布。发布后公司将于美东时间下午 4:30 举行电话会议和网络直播，讨论财务业绩并提供业务更新，直播回放将在活动结束后保留 90 天。
, /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today announced that its third quarter 2026 financial results will be released after the market close on November 10, 2026. Following the release, INOVIO will host a live conference call and webcast at 4:30 p.m. ET to discuss the financial results and provide a general business update.
A live webcast of the call will be available on the company's website at https://ir.inovio.com/events-and-presentations. The webcast will be archived and available for replay for 90 days following the event.
About INOVIO
INOVIO is a biotechnology company focused on developing and commercializing innovative DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases. INOVIO's technology optimizes the design and delivery of DNA medicines that enable the body to manufacture its own disease-fighting tools. For more information, visit www.inovio.com
Contacts
Media: Josephine Galatioto - ICR Healthcare, [email protected]
Investors: Peter Vozzo - ICR Healthcare, (443) 213-0505, [email protected]
SOURCE INOVIO Pharmaceuticals, Inc.
来源：PR Newswire Health · prnewswire.com